Clinical Trial Update: Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the efficacy of anti-CFA/I and CfaE bovine milk immunoglobulin to prevent diarrhea after challenge with CFA/I-expressing Enterotoxigeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• Anti-CFA/I and CfaE bovine milk immunoglobulin (bovine milk immunoglobulin targeting CFA/I and CfaE)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Diarrhea | Phase 1 | Status: COMPLETED